Skip to content

Comparative study of outcome of Topical steroid application compared with traditional dressing for non healing wound in burn patients,

Efficacy of topical steroid in treatment of hyper granulation tissue in burn patients: A randomized control trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617001058369
Enrollment
32
Registered
2017-07-19
Start date
2017-07-24
Completion date
2017-10-14
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

After getting approval from the ethical committee of our hospital .Total 32 patients who fulfill our inclusion criteria will be enrolled in our study. An inform consent will be taken from each patient. All cases will underwent surgical debridement and split thickness skin grafting. We will randomized select the patients into two groups with secondarily graft loss area less than 5cm2 by lottery method. In Group A, we will apply Topical 1% Hydrocortisone (Fusidin-H cream) and Group B will be managed with Medicated Paraffin gauze (bactigrass) dressing. Steroid will be applied topically thinly smeared once daily with 4x4 inch gauze piece onto wound bed. We will observe and access the wound weekly with visual and photographic evaluation that will be done by two consultant plastic surgeons. During the dressing changes, routine digital photographs will be taken with the signed consent of the patient/guardian for the purposes of treatment, teaching and use in academic publications. Time to complete wound healing was noted and defined as the number of days from application of steroid until epithelialization. Percentage of total body surface area burned, sex, age, burn mechanism, complications (burning skin, dry skin, and itching, increased hair growth at application site) and presence of hyper granulation tissue were assessed and correlated with time to complete wound healing.

Interventions

In Group A we will apply Topical 1% Hydrocortisone (Fusidin-H cream) thinly smeared once daily with 4x4 inch gauze piece onto wound bed by the dresser. Primary researcher will follow the patient for intervention adherence and will note in data. During the dressing changes, routine digital photographs will be taken. Duration of treatment will be till the wound healed (epithelialized). Time to complete wound healing will be noted and defined as the number of days from application of steroid until

In Group A we will apply Topical 1% Hydrocortisone (Fusidin-H cream) thinly smeared once daily with 4x4 inch gauze piece onto wound bed by the dresser. Primary researcher will follow the patient for intervention adherence and will note in data. During the dressing changes, routine digital photographs will be taken. Duration of treatment will be till the wound healed (epithelialized). Time to complete wound healing will be noted and defined as the number of days from application of steroid until complete epithelialization.

Sponsors

Farrukh Aslam Khalid
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
13 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

Non healing wound < 5 cm(square) in burn patients due to split skin graft loss

Exclusion criteria

Sepsis Culture positive wounds Pregnancy Patients is on steroids (immunocompromised)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026